NTEC News and Press, Intec Pharma Ltd. From 05/23/19

Editor's note: Seeking Alpha is proud to welcome James Mase as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » Thesis Tetra...

JERUSALEM , May 20, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the European Patent Office has granted the Company European Patent No. 2997953 titled, "DELIVERY DEVICE FOR ORAL INTAKE OF AN AGENT," and covers Intec's gastro-retenti...

Iovance Biotherapeutics (NASDAQ: IOVA ) +36%  on positive TIL data . More news on: Iovance Biotherapeutics, Inc., CUI Global, Inc., MacroGenics, Inc., Stocks on the move, Read more ...

NEW YORK , May 16, 2019 /PRNewswire/ --Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces it has entered into an agreement with Merck, known as MSD outside the United States and Canada , to explore using the Accordion Pill ® (AP) platform for an undisclos...

On today’s podcast, we sit down with Dan Ahrens, the portfolio manager of the AdvisorShares Pure Cannabis ETF ( YOLO ), the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. Dan is no stranger to the investing in vice stocks (tobacco...

Intec Pharma (NASDAQ: NTEC ): Q1 GAAP EPS of -$0.32 beats by $0.05. More news on: Intec Pharma Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

JERUSALEM , May 7, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three months ended March 31, 2019 and provides a corporate update.  Highlights of the first quarter 2019 and recent weeks include: ...

JERUSALEM , May 2, 2019 /PRNewswire/  -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the results from a pharmacokinetics (PK) study of the Accordion Pill™-Carbidopa/Levodopa (AP-CD/LD) 50/500 mg dosed three times per day (TID) was accepted...

JERUSALEM , April 30, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the last patient has completed their final visit in the Company's pivotal Phase 3 trial (the ACCORDANCE trial) evaluating the safety and efficacy of the Accordion Pi...

JERUSALEM , April 1, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate in the upcoming HC Wainwright Global Life Sciences Conference. HC Wainwright Global Life Sciences Conference Dat...